Why the study?
Does perioperative atenolol reduce perioperative myocardial ischemia and long-term mortality in patients at risk for coronary artery disease undergoing noncardiac surgery?
Population
Patients at risk for coronary artery disease undergoing noncardiac surgery
Comparison
Beta-adrenergic antagonist administered… vs Placebo
Design
Editorial, randomized, double-blind
Follow-up
2 yr
Authors
Loading...
Perioperative administration of beta-blockers in patients at risk for coronary artery disease undergoing noncardiac surgery is strongly advocated to reduce ischemia and long-term mortality.
Does perioperative atenolol reduce perioperative myocardial ischemia and long-term mortality in patients at risk for coronary artery disease undergoing noncardiac surgery?
Perioperative administration of beta-blockers in patients at risk for coronary artery disease undergoing noncardiac surgery is strongly advocated to reduce ischemia and long-term mortality.
David C. Warltier (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: